ClinicalTrialsFinder
RecruitingPhase 4NCT04666454

BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome.

BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome. A Multinational, Multicentre, Registry-based, Open-label, Randomized Controlled Trial.

Sponsor

Vastra Gotaland Region

Enrollment

1,000 participants

Start Date

Dec 14, 2020

Study Type

INTERVENTIONAL

Conditions

Takotsubo Syndrome

Summary

The aim of this study is to document an optimized pharmacologic treatment for patients with Takotsubo Syndrome. There is currently no published documentation in a large number of patients. The study is a Randomized Registry Clinical Trial and in total 1000 patients registered in SWEDEHEART will be included.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Adenosine, a drug called Apixaban 5 mg Oral Tablet, and others for people with takotsubo syndrome. The study is currently recruiting participants at 16 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAdenosine

Adenosine infusion 70 µg/kg/min for 3 hours.

DRUGDipyridamole 200 mg

200 mg b.i.d

DRUGApixaban 5 mg Oral Tablet

5mg b.i.d

OTHERCare as recommended by the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology for takotsubo syndrome

This treatment will vary depending on local routines and the degree of adherence to the recommendations.

Locations(16)

Aarhus Universitetshospital

Aarhus, Denmark

Rigshospitalet

Copenhagen, Denmark

Oslo University Hospital

Oslo, Norway

Östersund Sjukhus

Östersund, Jämtland Härjedalen, Sweden

Region Jönköpings Län

Jönköping, Region Jönköping, Sweden

Norra Älvsborgs länssjukhus

Trollhättan, Västra Götalands Region, Sweden

Region Dalarna

Falun, Sweden

Sahlgrenska University Hospital, Department of Cardiology

Gothenburg, Sweden

Skaraborg Hospital

Gothenburg, Sweden

Region Skane Helsingborg Hospital

Helsingborg, Sweden

Region Oestergoetland

Linköping, Sweden

Region Skane - Skanes Universitetssjukhus

Lund, Sweden

Region Orebro lan

Örebro, Sweden

Danderyds Hospital, Department of Cardiology

Stockholm, Sweden

Karolinska University Hospital, Huddinge, Department of Cardiology

Stockholm, Sweden

Umeå University Hospital, Department of Cardiology

Umeå, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04666454

Related Trials

The GErman Italian Spanish Takotsubo (GEIST) Registry

NCT043619942 locations

Mechanisms And Prognosis of Stroke-Heart Syndrome

NCT069541031 location

Takotsubo Syndrome and Air Pollution

NCT057318301 location

Unravelling the Mechanisms Underpinning the Broken Heart Syndrome

ACTRN126210006358642 locations

Polish Registry of Takotsubo Syndrome

NCT046344871 location